Search

Meeting Coverage:

American Society of Retina Specialists Annual Meeting

ASRS: 2017

Remaining Cost Effective with 'Slurry' Kenalog

Susan M. Malinowski, MD

Show Description +

Susan M. Malinowski, MD, describes an alternative to long-term steroid use in patients with diabetic macular edema (DME) using centrifuged intravitreal triamcinolone acetonide (“slurry” Kenalog, Bristol-Myers Squibb). Citing the ever-rising cost of treating DME, Dr. Malinowski points to the benefits of slurry Kenalog as an easy and inexpensive substitute.

Posted: 8/09/2017

Keywords:

Diabetic macular edema, DME

•

Slurry Kenalog

Up Next

Novel Technique for Visual Recovery Testing

Novel Technique for Visual Recovery Testing

John B. Miller, MD

Real-World Outcomes of Anti-VEGF Therapy in DME

Real-World Outcomes of Anti-VEGF Therapy in DME

Thomas A. Ciulla, MD, MBA

Intraoperative OCT in Subretinal Therapeutic Delivery

Intraoperative OCT in Subretinal Therapeutic Delivery

Lejla Vajzovic, MD

Cytogenetics in Uveal Melanoma

Cytogenetics in Uveal Melanoma

Carol Shields, MD

Revisiting VISTA: Nonperfusion and Aflibercept

Revisiting VISTA: Nonperfusion and Aflibercept

Charles Wykoff, MD, PhD

Açai-based Surgical Dye

Açai-based Surgical Dye

Mauricio Maia, MD, PhD

DEL MAR: Phase 2, Stage 2

DEL MAR: Phase 2, Stage 2

David S. Boyer, MD

Mapping Perfusion Density

Mapping Perfusion Density

Richard B. Rosen, MD, DSc(Hon)

Advances in Endoillumination

Advances in Endoillumination

David Chow, MD

Preoperative Anti-VEGF Therapy During Vitrectomy

Preoperative Anti-VEGF Therapy During Vitrectomy

Manish Nagpal, MD, FRCS

Digitally Assisted Vitreoretinal Surgery

Digitally Assisted Vitreoretinal Surgery

Marco Mura, MD

Novel Technique for Steroid Injection

Novel Technique for Steroid Injection

Michael Singer, MD

Treatments for VMT

Treatments for VMT

Nathan C. Steinle, MD

Back to All Videos

Remaining Cost Effective with 'Slurry' Kenalog

Susan M. Malinowski, MD

Susan M. Malinowski, MD, describes an alternative to long-term steroid use in patients with diabetic macular edema (DME) using centrifuged intravitreal triamcinolone acetonide (“slurry” Kenalog, Bristol-Myers Squibb). Citing the ever-rising cost of treating DME, Dr. Malinowski points to the benefits of slurry Kenalog as an easy and inexpensive substitute.

Posted: 8/09/2017

Keywords:

Diabetic macular edema, DME

•

Slurry Kenalog

Please log in to leave a comment.

More From ASRS: 2017 Coverage

DEL MAR: Phase 2, Stage 2

DEL MAR: Phase 2, Stage 2

David S. Boyer, MD

Mapping Perfusion Density

Mapping Perfusion Density

Richard B. Rosen, MD, DSc(Hon)

Advances in Endoillumination

Advances in Endoillumination

David Chow, MD

Preoperative Anti-VEGF Therapy During Vitrectomy

Preoperative Anti-VEGF Therapy During Vitrectomy

Manish Nagpal, MD, FRCS

Bryn Mawr Communications, LLC, and Eyetube.net are not affiliated with the official program of ASRS: 2017.